FR2908310B1 - Produits agonistes de tgr5 et leurs applications - Google Patents

Produits agonistes de tgr5 et leurs applications

Info

Publication number
FR2908310B1
FR2908310B1 FR0704278A FR0704278A FR2908310B1 FR 2908310 B1 FR2908310 B1 FR 2908310B1 FR 0704278 A FR0704278 A FR 0704278A FR 0704278 A FR0704278 A FR 0704278A FR 2908310 B1 FR2908310 B1 FR 2908310B1
Authority
FR
France
Prior art keywords
tgr5
applications
agonist products
agonist
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0704278A
Other languages
English (en)
Other versions
FR2908310A1 (fr
Inventor
Regis Saladin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHYTODIA
Centre National de la Recherche Scientifique CNRS
Universite Louis Pasteur Strasbourg I
Original Assignee
PHYTODIA
Centre National de la Recherche Scientifique CNRS
Universite Louis Pasteur Strasbourg I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0609930A external-priority patent/FR2908309A1/fr
Application filed by PHYTODIA, Centre National de la Recherche Scientifique CNRS, Universite Louis Pasteur Strasbourg I filed Critical PHYTODIA
Priority to FR0704278A priority Critical patent/FR2908310B1/fr
Priority to EP07870278A priority patent/EP2100139A2/fr
Priority to PCT/FR2007/001869 priority patent/WO2008074935A2/fr
Priority to JP2009536760A priority patent/JP2010509390A/ja
Publication of FR2908310A1 publication Critical patent/FR2908310A1/fr
Application granted granted Critical
Publication of FR2908310B1 publication Critical patent/FR2908310B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/52—Juglandaceae (Walnut family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2407/00—Assays, e.g. immunoassays or enzyme assays, involving terpenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/02—Nutritional disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
FR0704278A 2006-11-14 2007-06-15 Produits agonistes de tgr5 et leurs applications Expired - Fee Related FR2908310B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0704278A FR2908310B1 (fr) 2006-11-14 2007-06-15 Produits agonistes de tgr5 et leurs applications
EP07870278A EP2100139A2 (fr) 2006-11-14 2007-11-13 Compositions biologiquement actives, procédé pour leur obtention, et applications biologiques
PCT/FR2007/001869 WO2008074935A2 (fr) 2006-11-14 2007-11-13 Compositions biologiquement actives, procédé pour leur obtention, et applications biologiques
JP2009536760A JP2010509390A (ja) 2006-11-14 2007-11-13 生物活性組成物、その製造方法、および生物学的応用

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0609930A FR2908309A1 (fr) 2006-11-14 2006-11-14 Compositions biologiquement actives,procede pour leur obtention,et applications biologiques
FR0704278A FR2908310B1 (fr) 2006-11-14 2007-06-15 Produits agonistes de tgr5 et leurs applications

Publications (2)

Publication Number Publication Date
FR2908310A1 FR2908310A1 (fr) 2008-05-16
FR2908310B1 true FR2908310B1 (fr) 2009-07-10

Family

ID=39301056

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0704278A Expired - Fee Related FR2908310B1 (fr) 2006-11-14 2007-06-15 Produits agonistes de tgr5 et leurs applications

Country Status (4)

Country Link
EP (1) EP2100139A2 (fr)
JP (1) JP2010509390A (fr)
FR (1) FR2908310B1 (fr)
WO (1) WO2008074935A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009146772A1 (fr) * 2008-06-07 2009-12-10 Merck Patent Gmbh Nouveaux terpènes et macrocycles
JP5466842B2 (ja) * 2008-10-29 2014-04-09 ポーラ化成工業株式会社 グルタチオン産生促進組成物
WO2010100653A2 (fr) 2009-02-02 2010-09-10 Laila Nutraceuticals Composition provenant de sphaeranthus indicus et de garcinia mangostana pour maîtriser le syndrome métabolique
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
DK3149019T3 (da) * 2014-05-29 2020-02-17 Bar Pharmaceuticals S R L Cholan-derivater til anvendelse ved behandling og/eller forebyggelse af FXR- og TGR5/GPBAR1-formidlede sygdomme
JP2016008196A (ja) * 2014-06-24 2016-01-18 花王株式会社 Ｔｇｒ５活性化剤
JP6381316B2 (ja) * 2014-06-24 2018-08-29 花王株式会社 Ｔｇｒ５活性化剤
JP2016199536A (ja) * 2015-04-07 2016-12-01 株式会社ニュートリション・アクト 筋肉増強およびメタボリックシンドローム改善ならびにｑｏｌ改善のための組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6998249B1 (en) * 1999-09-27 2006-02-14 Pharmacia & Upjohn Company Toxicity screening method
JP2005021151A (ja) * 2002-11-12 2005-01-27 Takeda Chem Ind Ltd スクリーニング方法
WO2006054370A1 (fr) * 2004-11-16 2006-05-26 Use-Techno Corporation Agents d’inhibition de la gluconeogenese
JP2008169236A (ja) * 2007-01-09 2008-07-24 Toyobo Co Ltd 非熱可塑性ポリイミド非平面性成形品及びその製造方法

Also Published As

Publication number Publication date
WO2008074935A3 (fr) 2008-09-12
EP2100139A2 (fr) 2009-09-16
JP2010509390A (ja) 2010-03-25
FR2908310A1 (fr) 2008-05-16
WO2008074935A2 (fr) 2008-06-26

Similar Documents

Publication Publication Date Title
FR2908310B1 (fr) Produits agonistes de tgr5 et leurs applications
BRPI0717810A2 (pt) Produto de reação macromolecular; e composição
BRPI0716147A2 (pt) modificaÇço dinÂmica de propriedades de vÍdeo
BRPI0906980A2 (pt) Composição de derivados e maleatados
DK2139490T3 (da) Diazo-bicykliske smac-mimetiske stoffer og anvendelser deraf
DOP2007000084A (es) Derivados de dihidropirazolopirimidinona
DK2047098T3 (da) Kalibreringsfremgangsmåde
BRPI0810179A2 (pt) Composições de oligo-guluronato e galacturonato
DK2142529T3 (da) Trpv1-antagonister og anvendelser deraf
DK2034951T3 (da) Rehydererbart farmaceutisk produkt
DK2012773T3 (da) Lægemidler og anvendelser deraf
BRPI0716784A2 (pt) Produtos de wafer comestíveis produzidos através de extrusão
DK2083637T3 (da) Fibrøst fødevaremateriale
FR2938553B1 (fr) Produits en alliage aluminium-cuivre-lithium
BRPI0809441A2 (pt) Formulação farmacêuticas de moléculas ghrh
CR10809A (es) Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona
FR2898492B1 (fr) Comprimes orodispersibles de domperidone
DK2274619T3 (da) Slimhindereceptor og anvendelser deraf
BRPI0719228A2 (pt) Composição estabilizada de prostaglandina e
DK2097469T3 (da) Stabile laktidpartikler
DK2406372T3 (da) Prægastrisk esterase og derivater deraf
DK2406280T3 (da) Biologiske materialer og anvendelser deraf
BRPI0719964A2 (pt) Produto coextrudado
FR2907786B1 (fr) Thionucleosides et applications pharmaceutiques
DK2231603T3 (da) Substituerede 3-hydroxypyridiner og farmaceutiske sammensætninger deraf

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20150227